Conservative MPs are urging Canada’s auditor general to investigate the federal government’s management of the $250-million PrescribeIT program, which is set to be terminated on May 29. Launched in 2017 to modernize prescription transmission from doctors to pharmacies, the program has reportedly seen less than five percent usage among prescriptions. Initially budgeted at $40 million, the total cost has exceeded $300 million over the years. Conservative health critic Dan Mazier criticized the government’s handling of the program, highlighting concerns over the lack of knowledge among Canadians regarding PrescribeIT and the ongoing reliance on fax machines for prescriptions. Bloc Québécois MP Maxime Blanchette-Joncas supported calls for an inquiry, emphasizing management deficiencies in IT contracts. In response, the federal Health Minister’s office stated the program was deemed non-viable due to low uptake and that ending it was a financially responsible decision.
Why It Matters
The PrescribeIT program was intended to modernize Canada’s healthcare system by facilitating electronic prescriptions, thereby phasing out outdated practices like faxing. Despite significant government investment, the low adoption rate raises questions about the effectiveness of the program and the management of public funds. Canada Health Infoway, the organization overseeing PrescribeIT, revealed that the intellectual property developed through taxpayer funding primarily belongs to Telus Health, the company contracted to create the software. This situation underscores ongoing concerns about transparency and accountability in federal IT initiatives, which have historically faced scrutiny over cost overruns and management challenges.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
